It is not only the patients that are now interested in the research and development of new drugs. The interest in high-value-added industry and aspirations for the development of the domestic industry has never been hotter.

Industry development is good. New drugs? Even better. However, the rise of the stock market bubble that stirs investment interest in the sector is potentially detrimental to the advancement and success of the industry and new drug discovery.

New drug development would not have risen as a trend if it was easy. Due to rising interest in Korea's biopharmaceutical industry grows, information about the pharmaceutical industries’ clinical trial failures, discontinuation,